| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d8d30805708f0d2affd52c695145421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4743513aff767dd843a187da4ec85b07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00703b89e655f38305d79cb4f618b6bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0e7dfce989565c19cd11d578c4cdf75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11488c822321cf1cd95149b72fed498d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19ab97b38db4b4f2d9f2b00d0604d79d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-723 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2010-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa3e2f862b8a780ed882519858b1af8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a3df6491c6169a5d17470f1d007da15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb9cb72a04cb082b59ab4236109d6245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcfb54f1b43e9141059eb00434bb9913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eecae0e8c8a290df6ba0f563074b407 |
| publicationDate |
2010-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010116002-A1 |
| titleOfInvention |
Method for determining the estrogen receptor status of breast cancer |
| abstract |
The present invention relates to a method for determining the estrogen receptor status of patients suffering from breast cancer. The present invention also aims to provide methods and devices for predicting the response of patients diagnosed with breast cancer to specific medicaments. More specifically, the present invention provides methods which measure kinase activity by studying phosphorylation levels and profiles in samples obtained from patients diagnosed with breast cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013037972-A1 |
| priorityDate |
2009-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |